Indian drug major Sun Pharmaceutical Industries Ltd on Saturday said it closed second quarter of 2015-16 with a lower net loss, at Rs.601.32 crore as compared to net loss of Rs.685.90 crore for the same quarter of 2014-15.
In a regulatory filing with BSE, the company said its total income for the period under review went down to Rs.1,677.53 crore down from Rs.1,789.39 crore for the same quarter previous year.
